Dr Preston stated in his evidence to the Inquiry that whilst the hepatitis risk from commercial products was substantially greater than from NHS products, "there were insufficient NHS products for the treatment of Royal Hallamshire Hospital patients".
Chronology Information
Date:
Chapter/issue
Haemophilia Centres: Policies and Practice
Key Person(s)
Professor Francis Eric Preston